Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective.
The advent of anti-HER2 targeted therapies has dramatically improved the outcome of HER2-positive breast cancer; however, resistance to treatment in the metastatic setting remains a challenge, highlighting the need for novel therapies. The arrival of new treatment options and clinical trials examini...
| Published in: | Current Oncology Vol. 29; no. 4; pp. 2720 - 2735 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
MDPI
Apr2022
|
| Online Access: | View this record in EBSCOhost |